Aug. 11, 2010 -- Potiga, a new epilepsy drug, should be approved in the U.S. as an add-on treatment, an FDA expert advisory panel today voted.Potiga, known generically as ezogabine in the U.S. and as retigabine elsewhere, works differently than current epilepsy drugs. That's a good thing, as about a...
Read more